Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

614
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
614
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

65.1K
Overview
65.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

526
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
526

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synovial chondromatosis.

QJM : monthly journal of the Association of Physicians·2022
Same author

Surgical feasibility and long-term outcome of superior vena cava replacement for advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy.

Thoracic cancer·2021
Same author

Venous thromboembolism after adult thymus or thymic tumor resection: A single-center experience.

Thoracic cancer·2020
Same author

Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method.

Thoracic cancer·2020
Same author

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report.

Thoracic cancer·2019

Related Experiment Video

Updated: May 9, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

15.8K

Novel modulation of T effector memory cells-expressing CD45RA by prednisone in inoperable advanced type B thymoma

Xin-Tao Yu1, Jian Cui1, Xing-Guo Yang1

  • 1Department of Thoracic Surgery, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Dongcheng District, Beijing City, 100730, China.

Genes and Immunity
|May 6, 2025
PubMed
Summary
This summary is machine-generated.

Prednisone acetate effectively shrinks thymoma, particularly types B1 and B2. This treatment shows promise for advanced thymoma stages, with interleukin-8 positive TEMRA cells as a potential biomarker.

More Related Videos

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.0K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.0K

Related Experiment Videos

Last Updated: May 9, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
15:33

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

15.8K
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.0K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.0K

Area of Science:

  • Oncology
  • Immunology

Background:

  • Thymoma diagnosis often occurs at advanced stages (III-IV) due to subtle onset, limiting surgical options.
  • Refractory thymoma presents a treatment challenge, necessitating exploration of alternative therapeutic strategies.

Purpose of the Study:

  • To evaluate the efficacy of prednisone acetate in treating thymoma.
  • To identify potential biomarkers for predicting response to prednisone acetate therapy.

Main Methods:

  • A study involving 96 thymoma patients treated with prednisone acetate.
  • Tumor shrinkage assessed via reduced diameter ratio.
  • Immunofluorescence and flow cytometry used to analyze TEMRA cells and interleukin-8 expression in tumor tissues.

Main Results:

  • Prednisone acetate treatment resulted in significant thymoma tumor shrinkage.
  • Types B1 and B2 thymomas, especially B2, showed the most substantial response.
  • Interleukin-8 positive TEMRA cells decreased in B1 and B2 thymoma tissues post-treatment, suggesting a potential predictive biomarker.

Conclusions:

  • Prednisone acetate is effective in reducing thymoma size, particularly in B1 and B2 subtypes.
  • The decrease in interleukin-8 positive TEMRA cells after treatment may indicate responsiveness to prednisone acetate.
  • Findings offer therapeutic implications for advanced-stage B1 and B2 thymoma patients.